PhRMA
JULY 12, 2023
This week, PhRMA submitted comments to the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) regarding the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization draft. In our comments, we expressed our strong opposition to policy proposals that would inhibit the biopharmaceutical industry partnering with the government to address pressing public health needs.
Pharmacy Times
JULY 12, 2023
Optimizing efforts to treat patients using medication for opioid use disorder with cognitive disfunction can improve PrEP treatment rates and reduce overall rates of HIV infection, a recent study indicates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 12, 2023
Three new bills signed Monday will require PBMs to use prescription drug rebates to lower premiums and out-of-pocket costs for consumers and prevent the practice of spread pricing.
Pharmacy Times
JULY 12, 2023
Study shows equivalent overall survival among younger adults with acute lymphoblastic leukemia aged 15 to 29 and older adults aged 30 to 50 with normal BMI.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JULY 12, 2023
Numerous tools, technology platforms, and interventions have been developed to help teens with the difficult emotional and physical weight of managing the disease.
Pharmacy Times
JULY 12, 2023
Older adults are vulnerable to severe influenza-associated complications and risks, but influenza vaccines may be less effective in this population.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 12, 2023
Fecal microbiota transplantation is a process that restores bacterial diversity in the gut microbiome after standard-of-care antimicrobial therapy.
Fierce Healthcare
JULY 12, 2023
CVS Caremark is teaming with GoodRx to provide pharmacy discounts to commercial plan customers. | CVS Caremark is teaming with GoodRx to provide pharmacy discounts to commercial plan customers.
Pharmacy Times
JULY 12, 2023
Further research and regulatory changes are needed, but psychedelic medicines may be able to treat or even cure mental illness in the future.
Fierce Pharma
JULY 12, 2023
As another SGLT2 diabetes drug hits the market, the obvious question is: How will it find a way to compete against formidable blockbusters Farxiga and Jardiance? | TheracosBio and Mark Cuban's online distributor Cost Plus Drug Company have partnered to provide newly approved SGLT2 inhibitor Brenzavvy at a major discount to competitors in the class, including AstraZeneca's Farxiga and Eli Lilly and Boehringer Ingelheim's Jardiance.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 12, 2023
Despite injection site adverse effects, the overall benefit-risk balance for pneumococcal vaccination remains favorable.
Fierce Pharma
JULY 12, 2023
Merck is bringing more heat in its battle against drug price negotiation provisions in the Inflation Reduction Act (IRA), filing Tuesday in federal court in Washington, D.C. | Merck is bringing more heat in its battle against drug price negotiation provisions in the Inflation Reduction Act (IRA), filing Tuesday for a decision without a trial. In its request for a summary judgment, Merck reiterated its claim that the drug price negotiation program violates the First and Fifth Amendments of the Co
Pharmacy Times
JULY 12, 2023
A panel of experts discuss those most at risk for complications from the flu, and how flu vaccines may benefit them.
Fierce Healthcare
JULY 12, 2023
LGBTQ+ founders have created 36% more jobs, 114% more patents and 44% more exits than the average founder, according to a research index by StartOut, a nonp | “It’s still hard when you’re pitching across the table to people that just see the world very differently," said David Stein, CEO and co-founder of Ash Wellness. On the heels of Pride Month, LGTBQ+ founders reflect on the struggle of building a startup and fundraising in the U.S. while maintaining their identity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JULY 12, 2023
Using artificial intelligence to sort and respond to patient queries could streamline processes and alleviate provider burnout.
STAT
JULY 12, 2023
The nation’s widespread racial health disparities won’t be erased without changes to how health care systems are funded and accredited, more public and financial accountability for poor patient outcomes, and more work to overturn the income inequality and residential segregation tied to poorer health and lower life expectancy for many people who are Black and brown.
Fierce Pharma
JULY 12, 2023
Five weeks after getting no response from the U.S. | Five weeks after getting no response from the U.S. Department of Health and Human Services on his request for more information on the potential financial impact of Eisai and Biogen’s newly approved Alzheimer’s treatment Leqembi, Sen. Bernie Sanders (I-Vt.) has sent a follow-up letter to the HHS. The drug has been priced at $26,500 per patient per year.
STAT
JULY 12, 2023
One year after 988 launched as the new number for the national U.S. mental health hotline, the people behind the system say they’re still working out some kinks. In an ideal world, for example, a caller in New York looking to talk would be routed to a New York call center, so that hotline workers could direct them to the most relevant information on local resources.
Fierce Healthcare
JULY 12, 2023
Private sector data companies like Komodo Health work with healthcare stakeholders, including governments, to help identify gaps in care, inequities and then interventions to improve outcomes. | This week on "Podnosis," we talk about how big data can inform policy. Also under discussion is the role of AI in healthcare.
Pharma Marketing Network
JULY 12, 2023
The internet is a vast resource of information on health and wellness. However, not all of this information is created equal. Some of it is accurate and reliable, while other information may be misleading or even harmful. This is especially true when it comes to pharmaceutical-sponsored health information. Pharmaceutical companies have a vested interest in promoting their products, so it’s important to be critical of any information they put out.
STAT
JULY 12, 2023
The treatment of sickle cell disease is on the cusp of a historic breakthrough, with makers of two gene-based treatments for the debilitating blood disorder hoping for regulatory approval this year. But for those with sickle cell in sub-Saharan Africa, where more than 60% of the 120 million people worldwide live with this disease, there is little cause to celebrate.
PharmExec
JULY 12, 2023
Recent data and commentary offer insights into how biologics vs. small molecule patent protections under the Inflation Reduction Act pricing scenarios is impacting investing in the biotech sector.
Fierce Pharma
JULY 12, 2023
Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach younger patients with its JAK inhibitor cream Opzelura. | Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach young patients with its JAK inhibitor cream Opzelura. But a classwide box warning could be a heavy burden for the med in a forthcoming market clash.
STAT
JULY 12, 2023
Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. Of course, no prescription is required, which is a good thing. Our choice today is gingerbread, for those tracking this sort of thing.
Fierce Pharma
JULY 12, 2023
A new triumvirate of biopharma bigwigs is in line to reign over one of the industry’s top trade groups. | The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has unveiled the upcoming lineup for its CEO leadership team over the next two years. Captaining the group as IFPMA’s new president and chair of the organization’s CEO steering committee will be Pfizer chief Albert Bourla.
Pharma Marketing Network
JULY 12, 2023
The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs.
Fierce Pharma
JULY 12, 2023
Two years after it enriched itself with 16 Sanofi drugs, Germany’s Stada Arzneimittel is purchasing another clutch of consumer health brands across multiple European countries. | Stada is dropping an undisclosed sum on a range of Sanofi consumer health products with “well-established” footholds in places such as Belgium, Germany, Hungary, Spain and the United Kingdom, plus Nordic countries.
European Pharmaceutical Review
JULY 12, 2023
The first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa, has been prequalified by the World Health Organization (WHO). MenFive ® has been developed through a 13-year collaboration between the world’s largest vaccine manufacturer Serum Institute of India Pvt. Ltd. (SIIPL) and PATH, with funding from the UK government.
Fierce Pharma
JULY 12, 2023
Lupin is no stranger to FDA rebukes, though its latest write-up from the U.S. drug regulator certainly could have been worse for the company. | Following an inspection of Lupin’s Pithampur Unit-2 manufacturing facility in Madhya Pradesh, India, from March 21 to March 29, the FDA handed the company an inspection with a classification of Voluntary Action Indicated.
Fierce Healthcare
JULY 12, 2023
While payers should cover telehealth, where these services are the most valuable still requires investigation, according to a stu | Telehealth can reduce utilization when used for mental health, skin problems, metabolic conditions, and musculoskeletal diseases, but doesn’t help cut costs for circulatory, respiratory, and infectious diseases, according to a new study.
STAT
JULY 12, 2023
WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment , insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests. Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease.
Fierce Healthcare
JULY 12, 2023
High-quality therapy can be expensive for a lot of individuals and it's estimated that one-third of therapists don't accept insurance at all. | The new funding will accelerate Octave’s expansion to more regions later this year and all 50 states in 2024.
STAT
JULY 12, 2023
Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.
Outsourcing Pharma
JULY 12, 2023
Lisa Moneymaker is full of energy, enthusiasm, and wisdom. She is well-known on the pharma circuit and itâs easy to see why. She has been chief technology officer and chief product officer at Saama since October last year and feels passionately about women in science and women in general â and although her journey was without many challenges, she appreciates that is not the case for everyone.
Expert insights. Personalized for you.
233 
Let's personalize your content